Skip to main content
OpenTrials
Completed

NCT Number: NCT03187574

Comparison of Two Vaginal Mesh Kits in the Management of Vaginal Prolapse

Our study is a non-randomized prospective study compared two groups matched for anterior/apical POP-Q grade: 84 received Elevate Ant™ single-incision mesh (group A) and 42 Perigee™ transvaginal mesh (group B). The study hypothesis was that the Elevate Ant™ mesh would provide better apical correction than the Perigee™ mesh. One- and 2-year follow-up comprised anatomic assessment (POP-Q) and QoL (PFDI-20, PFIQ-7, PISQ-12). Success was defined as 2-year POP-Q ≤1. Secondary endpoints were function and complications.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • symptomatic patient presenting with POP-Q grade ≥3 anterior or apical prolapse

Treatment and study plan

Elevate Ant™

Device

Surgery with Elevate Ant™

Perigee™

Device

Surgery with Perigee™

Primary outcomes

  1. comparison of anatomic correction rates in the vaginal apex at 1 year between two mesh kits

    Time frame: 1 year post-surgery

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

A Prospective Comparison of Two Vaginal Mesh Kits in the Management of Anterior and Apical Vaginal Prolapse: Long Term-results for Apical Fixation and Quality of Life

Acronym: ELEPE

Important dates

Study start
2009
Primary completion
2015
Study completion
2016
First posted
Jun 15, 2017
Registry last updated
Jun 19, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.